TRULICITY 1.5 MG - AN OVERVIEW

1) and Drug Interactions (7)]. The potential risk of hypoglycemia could possibly be reduced by a reduction inside the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Tell clients making use of these concomitant medications of the potential risk of hypoglycemia and teach them to the signals and indicators